Although results from our study provide the first evidence for VEGF 1451C > T, 1612G > A, and 1725G > A as potential biomarkers for CRC prevention, a prospective study on a larger cohort of patients is warranted to validate these findings. Here, VEGFA is linked to colorectal carcinoma.